EquityFlow
›
Investors
› Kotak Alternate Asset Managers
Kotak Alternate Asset Managers
Investor
At a glance
2 portfolio companies
2 rounds
2 led
$9.2M total
Portfolio
Company
Rounds
Invested
ZeroHarm Sciences
Consumer
1 round, 1 led
$7.2M
Cellogen Therapeutics
Biotech
1 round, 1 led
$2M
Frequently co-invests with
Alkemi Growth Capital
1
Explore investors on EquityFlow →